Japan’s New Ambassador to China Meets Detained Astellas Employee
14:30 JST, January 31, 2024
BEIJING (Jiji Press) — Kenji Kanasugi, Japan’s new Ambassador to China, met Tuesday with a Japanese employee of drugmaker Astellas Pharma Inc. who has been held by Chinese authorities on suspicion of espionage, diplomatic sources said.
During the meeting, the Astellas employee said he has no particular health problems, according to the sources.
The Japanese national was detained in Beijing last March, when he was about to go back to Japan after finishing his assignment in the country. He was formally arrested in October.
At a Japan-China summit in November, Prime Minister Fumio Kishida called on Chinese President Xi Jinping to release him at an early date.
It was the 10th meeting between the Astellas worker and a Japanese diplomat. Kanasugi’s predecessor, Hideo Tarumi, also met with him before leaving China.
"Politics" POPULAR ARTICLE
-
Japan PM Ishiba Says Corporate, Group Donations ‘Not Inappropriate’; Interpellations Start at Lower House
-
Japan’s LDP Proposes Third-Party Panel to Monitor Use of Political Funds; Draft Does Not Mention Banning Corporate Donations
-
Japan to Support Its Companies Expanding into Africa; Creating Initiative to Act as Bridge with Local Start-ups
-
Tourists’ Consumption Tax Exemption To Take New Form; Refunds When Departing To Replace Waivers When Buying
-
Japan, Italy, U.K. Launch Body To Manage Next-Generation Jet Project; U.K.-Headquartered Body Has Japanese Chief Executive
JN ACCESS RANKING
- Japan’s Kansai Economic Delegation Meets China Vice Premier, Confirm Cooperation; China Called to Expand Domestic Demand
- Yomiuri Stock Index to Launch in March; 333 Companies to be Equally Weighted
- China to Test Mine for Rare Metals Off Japan Island; Japan Lagging in Technologies Needed for Extraction
- Miho Nakayama, Japanese Actress and Singer, Found Dead at Her Tokyo Residence; She was 54 (UPDATE 1)
- Risk of Nuclear Weapons Being Used Greater Than Ever; Support Growing in Russia As Ukraine War Continues